Nivolumab and ipilimumab in combination with radiotherapy in patients with locally advanced head and neck cancer

被引：0
|
作者：
Johnson, J. M. [1 ]
Bar Ad, V. [2 ]
Lorber, E. [1 ]
Luginbuhl, A. [3 ]
Curry, J. M. [3 ]
Cognetti, D. [3 ]
Keith, S. [4 ]
Axelrod, R. [1 ]
Zinner, R. [1 ]
Rodeck, U. [5 ]
Harshyne, L. A. [6 ]
Argiris, A. [7 ]
机构：
[1] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Dept Radiat Oncol, Philadelphia, PA 19107 USA
[3] Thomas Jefferson Univ, Dept Otolaryngol, 1721 Pine St, Philadelphia, PA 19103 USA
[4] Thomas Jefferson Univ, Dept Pharmacol & Expt Therapeut, Philadelphia, PA 19107 USA
[5] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA
[6] Thomas Jefferson Univ, Dept Neurosurg, Philadelphia, PA 19107 USA
[7] Hygeia Hosp, Med Oncol, Athens, Greece
来源：
ANNALS OF ONCOLOGY | 2018年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1126TiP
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Population Pharmacokinetics of Nivolumab in Combination With Ipilimumab in Patients With Advanced Malignancies
    Zhang, Jason
    Sanghavi, Kinjal
    Shen, Jun
    Zhao, Xiaochen
    Feng, Yan
    Statkevich, Paul
    Sheng, Jennifer
    Roy, Amit
    Zhu, Li
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2019, 8 (12): : 962 - 970
  • [32] Is there any use in accelerated and hyperfractionated radiotherapy in locally advanced head and neck cancer?
    Monney, M
    Allal, A
    Guilleman, C
    Rosset, A
    Miralbell, R
    Kurtz, J
    Mirimanoff, RO
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 831 - 831
  • [33] Radiotherapy combined with cetuximab for locally advanced head and neck cancer: Results and toxicity
    Acevedo-Henao, C. M.
    Valette, G.
    Miglierini, P.
    Lefur, E.
    Pradier, O.
    CANCER RADIOTHERAPIE, 2012, 16 (07): : 601 - 603
  • [34] ROLE OF ADAPTIVE RADIOTHERAPY IN LOCALLY ADVANCED HEAD AND NECK CANCER: A DOSIMETRIC ANALYSIS
    Sharma, S. K.
    Dewan, A.
    Dewan, A. K.
    Pahuja, A.
    Pal, M.
    Rawat, S.
    Mitra, S.
    Sharma, M. K.
    Tandon, S.
    Narang, R.
    Mishra, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : E6 - E6
  • [35] Dosimetric study of Adaptive radiotherapy (ART) for locally advanced head and neck cancer
    Das, J.
    Goswami, B.
    Goswami, S.
    Deka, K. J.
    Bora, G.
    Das, L.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1271 - S1272
  • [36] Adaptive radiotherapy in locally advanced head and neck cancer: The importance of reduced margins
    Enocson, Hedda
    Haraldsson, Andre
    Engstrom, Per
    Ceberg, Sofie
    Gebre-Medhin, Maria
    Adrian, Gabriel
    Rosenschold, Per Munck af
    PHYSICS & IMAGING IN RADIATION ONCOLOGY, 2025, 33
  • [37] Hyperfractionated radiotherapy with concurrent docetaxel in locally-advanced head and neck cancer
    Karasawa, K.
    Izawa, H.
    Hirowatari, H.
    Ito, K.
    Furuya, T.
    Ozawa, S.
    Matsumoto, F.
    Ito, S.
    Oba, S.
    Ikeda, K.
    EJC SUPPLEMENTS, 2009, 7 (02): : 480 - 480
  • [38] Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer - A review of their cooperation
    Marcu, L
    van Doorn, T
    Olver, I
    ACTA ONCOLOGICA, 2003, 42 (04) : 315 - 325
  • [39] Hyperfractionated radiotherapy versus hyperfractionated radiotherapy and concomitant chemotherapy in locally advanced head and neck cancer
    Kasibhatla, M.
    Prosnitz, L. R.
    Fisher, S. R.
    Scher, R. L.
    Clough, R.
    Brizel, D. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S11 - S12
  • [40] Nivolumab (Nivo) and ipilimumab (Ipi) combined with radiotherapy (RT) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN): Updated results on efficacy and correlative analysis
    Vathiotis, I.
    Johnson, J. M.
    Harshyne, L.
    Luginbuhl, A.
    Curry, J. M.
    Cognetti, D.
    Axelrod, R.
    Bar-Ad, V.
    Argiris, A.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S850 - S850
12345